Gilead Sciences (GILD) Return on Equity [ROE] (2009 - 2026)
Gilead Sciences (GILD) posted Return on Equity [ROE] of -18.38% for Q2 2026, down 51.02 percentage points from 32.64% a year earlier and down 58.33 percentage points from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Gilead Sciences' Return on Equity [ROE] came in at 40.57%, up 38.29 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of +40.14 percentage points (FY2020 to FY2025).
- In prior years, Gilead Sciences' Return on Equity [ROE] was 2.29% in FY2024 (-23.25 pp), 25.54% in FY2023 (+3.94 pp), 21.60% in FY2022 (-9.97 pp) and 31.57% in FY2021 (+31.13 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q3 2009.
- On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of +4.94 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2025, with a gain of 38.81 percentage points; the weakest was Q2 2026, with a drop of 51.02 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 39.95% (Q1 2026), 38.47% (Q4 2025) and 39.44% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 22.24% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 43.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.38% |
| Mar 31, 2026 | 39.95% |
| Dec 31, 2025 | 38.47% |
| Sep 30, 2025 | 39.44% |
| Jun 30, 2025 | 32.64% |
| Mar 31, 2025 | 31.13% |
| Dec 31, 2024 | 2.55% |
| Sep 30, 2024 | 0.62% |
| Jun 30, 2024 | 5.79% |
| Mar 31, 2024 | 2.28% |
| Dec 31, 2023 | 24.95% |
| Sep 30, 2023 | 26.90% |
| Jun 30, 2023 | 25.90% |
| Mar 31, 2023 | 26.28% |
| Dec 31, 2022 | 21.61% |
| Sep 30, 2022 | 16.04% |
| Jun 30, 2022 | 20.48% |
| Mar 31, 2022 | 21.92% |
| Dec 31, 2021 | 29.16% |
| Sep 30, 2021 | 35.79% |
API Access
Gilead Sciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();